Technical Analysis for ZYXI - Zynex, Inc.

Grade Last Price % Change Price Change
grade D 17.04 1.31% 0.22
ZYXI closed up 1.31 percent on Friday, August 7, 2020, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ZYXI trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 1.31%
Oversold Stochastic Weakness 1.31%
Narrow Range Bar Range Contraction -5.96%
NR7 Range Contraction -5.96%
Inside Day Range Contraction -5.96%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Medicine Clinical Medicine Pain Surgery Medical Technology Pain Management Analgesics Neuromodulation Neurotechnology Neurophysiology Stroke Electrotherapy Spinal Cord Injury Cold Therapy Electrophysiology Transcutaneous Electrical Nerve Stimulation

Is ZYXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 29.73
52 Week Low 7.51
Average Volume 1,371,450
200-Day Moving Average 14.27
50-Day Moving Average 22.20
20-Day Moving Average 20.33
10-Day Moving Average 18.33
Average True Range 1.67
ADX 19.97
+DI 16.44
-DI 29.32
Chandelier Exit (Long, 3 ATRs ) 24.72
Chandelier Exit (Short, 3 ATRs ) 21.57
Upper Bollinger Band 25.45
Lower Bollinger Band 15.22
Percent B (%b) 0.18
BandWidth 50.31
MACD Line -1.56
MACD Signal Line -1.20
MACD Histogram -0.3559
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.15
Resistance 3 (R3) 18.16 17.80 17.97
Resistance 2 (R2) 17.80 17.51 17.79 17.91
Resistance 1 (R1) 17.42 17.34 17.24 17.41 17.84
Pivot Point 17.05 17.05 16.96 17.05 17.05
Support 1 (S1) 16.67 16.77 16.49 16.67 16.24
Support 2 (S2) 16.31 16.59 16.31 16.17
Support 3 (S3) 15.93 16.31 16.11
Support 4 (S4) 15.93